Precision Medicine in the Emergency Room
This study tests whether using genetic information in the emergency department can help choose safer medications for patients 40 and older. It focuses on people who frequently visit the ER and are starting a new long-term medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You are at an emergency department that is part of this study.
- You just got a new prescription for a medication that you'll take for more than a week (or had one within the last 30 days).
- You have been to the emergency room or urgent care at least twice in the past year.
- You have not already had genetic testing for how your body processes medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pharmacist review of your medications, plus information from a pharmacogenomic (PGx) test (which looks at how your genes affect your response to drugs), can help improve your medication plan. If you qualify, you'll get a free PGx test and a personalized medication review.
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
This study tests whether a cheek-swab DNA test can help doctors choose safer medicines for you. If you are starting a new drug in primary care, you might join to help prevent side effects.
This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.
This trial checks whether using a genetic (DNA) medication test—done within the last 120 days—can help reduce bad medication reactions and prevent readmissions to the hospital. It may help people whose medications have caused side effects or did not work well.
This study looks at whether a person’s genetic makeup can help choose safer medicines or improve how well treatment works. You may be asked for testing if you’ve had a bad reaction or treatment failure, or if you’re starting a new medicine that is known to be affected by genetics.
Hear when a new Pharmacogenomic Drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.